PubRank
Search
About
V P Castle
Author PubWeight™ 21.25
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
Anticancer Res
2000
1.46
2
Thrombospondin-1 induces endothelial cell apoptosis and inhibits angiogenesis by activating the caspase death pathway.
J Vasc Res
2000
1.42
3
NF-kappa B activation mediates doxorubicin-induced cell death in N-type neuroblastoma cells.
J Biol Chem
2001
1.39
4
Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma.
Cancer Res
1994
1.32
5
Bcl-xL is expressed in neuroblastoma cells and modulates chemotherapy-induced apoptosis.
Cancer Res
1995
1.30
6
Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin.
Am J Pathol
1997
1.23
7
Successful treatment of infantile hemangiomas with interferon-alpha-2b.
J Pediatr Hematol Oncol
1997
1.16
8
Reversal of protein-losing enteropathy with heparin therapy in three patients with univentricular hearts and Fontan palliation.
J Pediatr
1997
1.10
9
Neuroblastoma: positron emission tomography with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose compared with metaiodobenzylguanidine scintigraphy.
Radiology
1996
1.08
10
IGF-I receptor activation and BCL-2 overexpression prevent early apoptotic events in human neuroblastoma.
Cell Death Differ
2000
0.97
11
Insulin-like growth factor II in the pathogenesis of human neuroblastoma.
Am J Pathol
1995
0.94
12
Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells.
Cancer Res
1996
0.88
13
Bcl-2 and M-Myc coexpression increases IGF-IR and features of malignant growth in neuroblastoma cell lines.
Neoplasia
2001
0.87
14
Successful bone marrow transplantation in a patient with Schimke immuno-osseous dysplasia.
J Pediatr
2000
0.85
15
Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies.
Radiology
1995
0.84
16
Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells.
Mol Genet Metab
1998
0.82
17
Successful treatment of neonatal arterial thromboses with recombinant tissue plasminogen activator.
J Pediatr
1998
0.82
18
Neonatal purpura fulminans in association with factor V R506Q mutation.
J Pediatr
1996
0.82
19
Kasabach-Merritt syndrome: treatment with epsilon-aminocaproic acid and assessment by indium 111 platelet scintigraphy.
J Pediatr
1990
0.81
20
Fatal lymphoproliferative disease as a complication of Evans syndrome.
J Pediatr Hematol Oncol
2000
0.80
21
Congenital mesoblastic nephroma metastatic to the brain: a report of two cases.
Pediatr Radiol
1995
0.78
22
PET hydroxyephedrine imaging of neuroblastoma.
J Nucl Med
1996
0.77
23
The response to splenectomy in pediatric patients with idiopathic thrombocytopenic purpura who fail high-dose intravenous immune globulin.
J Pediatr Surg
2000
0.76
24
Lineage switch in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Cancer
1994
0.75